---
figid: PMC3765962__gr2
figlink: /pmc/articles/PMC3765962/figure/f0010/
number: F2
caption: Important molecular pathways and drug targets in RCC. Inactive VHL leads
  to increased concentrations of HIF-alpha subunits. The PI3K/mTOR pathway also increases
  expression of HIF-alpha subunits. The resulting transcriptional stimulation of the
  HIF response element HRE and the rise in VEGF production stimulates endothelial
  growth and increased vascular supply to the tumor. Targeted therapies inhibit a
  variety of molecules along the involved signaling cascades in both tumor and endothelial
  cells. VHL,Von Hippel Lindau; HIF, hypoxia-induced factor; HRE, HIF response element;
  VEGF, vascular endothelial growth factor; mTOR, mammalian target of rapamycin; MAPK,
  mitogen-activated protein kinase. Adapted with permission of Future Medicine Ltd.
pmcid: PMC3765962
papertitle: Adjuvant Therapy in Renal Cell Carcinomaâ€”Past, Present, and Future.
reftext: Tobias Janowitz, et al. Semin Oncol. 2013 Aug;40(4):482-491.
pmc_ranked_result_index: '9885'
pathway_score: 0.9636176
filename: gr2.jpg
figtitle: Important molecular pathways and drug targets in RCC
year: '2013'
organisms:
- Homo sapiens
ndex: ae59e74e-ded1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3765962__gr2.html
  '@type': Dataset
  description: Important molecular pathways and drug targets in RCC. Inactive VHL
    leads to increased concentrations of HIF-alpha subunits. The PI3K/mTOR pathway
    also increases expression of HIF-alpha subunits. The resulting transcriptional
    stimulation of the HIF response element HRE and the rise in VEGF production stimulates
    endothelial growth and increased vascular supply to the tumor. Targeted therapies
    inhibit a variety of molecules along the involved signaling cascades in both tumor
    and endothelial cells. VHL,Von Hippel Lindau; HIF, hypoxia-induced factor; HRE,
    HIF response element; VEGF, vascular endothelial growth factor; mTOR, mammalian
    target of rapamycin; MAPK, mitogen-activated protein kinase. Adapted with permission
    of Future Medicine Ltd.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF12
  - FGF13
  - FGF11
  - PIK3CA
  - PIK3CG
  - EPO
  - PIK3CB
  - FGF14
  - PIK3CD
  - AKT1
  - FGF10
  - PIK3R6
  - FGF16
  - VEGFC
  - AKT2
  - FGF9
  - PIK3R3
  - FGF20
  - FGF19
  - FLT1
  - FGF3
  - PIK3R5
  - PIK3R4
  - PGK1
  - FGF7
  - AKT3
  - LDHA
  - FGF8
  - MAPK1
  - MAPK11
  - ARAF
  - MAPK14
  - FGF21
  - FGF22
  - FGF4
  - FGF5
  - FGF6
  - FGF17
  - VEGFB
  - VEGFA
  - MAPK12
  - VHL
  - MAPK3
  - MAPK8
  - HK2
  - FGF1
  - FGF2
  - MTOR
  - FLT4
  - FGF23
  - FGF18
  - KDR
  - RAF1
  - BRAF
  - MAPK13
  - SLC2A1
  - PGF
  - MAPK9
  - MAPK10
  - VEGFD
  - HIF1A
  - HIF3A
  - SLC2A3
  - EPAS1
  - ARNT
  - Temsirolimus
  - Pazopanib
  - Cancer
genes:
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: EPO
  symbol: EPO
  source: hgnc_symbol
  hgnc_symbol: EPO
  entrez: '2056'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FLT1
  symbol: FLT1
  source: hgnc_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PGK1
  symbol: PGK1
  source: hgnc_symbol
  hgnc_symbol: PGK1
  entrez: '5230'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: LDH-A
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: HKII
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FLT4
  symbol: FLT4
  source: hgnc_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: KDR
  symbol: KDR
  source: hgnc_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: GLUT-1
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: GLUT-3
  symbol: GLUT3
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A3
  entrez: '6515'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: HIF-1B
  symbol: HIF-1beta
  source: hgnc_alias_symbol
  hgnc_symbol: ARNT
  entrez: '405'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Pazopanib
  source: MESH
  identifier: C516667
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3765962__F2
redirect_from: /figures/PMC3765962__F2
figtype: Figure
---
